Clinical Trials Logo

Clinical Trial Summary

This mobile application measures the level of certain hormones in the urine of a woman and is used to help pinpoint when the woman is/was most likely to get pregnant during her menstrual cycle.


Clinical Trial Description

The purpose of the study is to evaluate the accuracy of ovulation monitoring using hormone test strips in a digital way via a mobile application.

Ovulation prediction kits consist of test strips that measure three different hormones - LH (luteinizing hormone), FSH (follicle stimulating hormone), PdG (pregnanediol). Through daily testing with the mobile application, it is possible to measure these hormones and build hormonal profiles along the menstrual cycle. This way we can accurately predict and confirm ovulation, as well as calculate the most fertile days in the cycle.

There are multiple solutions that claim to accurately monitor fertility. However, some of these solutions use period statistics with high level of error, for example period trackers, or body temperature monitors. Some others use hormonal test strips in which reading/interpretation is not always easy. This study evaluates the accuracy of using hormone test strips in combination with an app that will digitally read and record data over time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03924453
Study type Observational
Source MFB Fertility
Contact
Status Completed
Phase
Start date December 1, 2017
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02264847 - Human Chorionic Gonadotrophin & Trigger Phase 3
Completed NCT03924440 - Ovulation Double Check (Proov) Verification and Usability Testing
Recruiting NCT04979377 - Prevalence of Hyperandrogenism in Type 1 Diabetes
Not yet recruiting NCT06292806 - Inhibin B/AFC Ratio for Ovarian Response
Completed NCT03309176 - "Stair Step Study" Phase 4
Not yet recruiting NCT03989024 - Pulsatile Gonadotropin-releasing Hormone for Infertility in Non-obese Patients With Polycystic Ovary Syndrome Phase 4
Completed NCT04942457 - Feasibility and Safety of Fasting in Fertility Treatment N/A
Not yet recruiting NCT02940535 - Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response N/A
Recruiting NCT04075149 - Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess? Early Phase 1
Recruiting NCT05211583 - Serial Progesterone Level Measurements During the Menstrual Cycle in Subfertile Women
Withdrawn NCT04002635 - Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) Phase 4
Completed NCT04210765 - Incremental Clomiphene Citrate Doses in Successive Cycles and FSH, LH and Steroid Hormone Levels Phase 4
Completed NCT01999569 - The Role of Estrogen in Luteinizing Hormone Surge and Ovulation Phase 4